Biomol Ther.  2023 Nov;31(6):655-660. 10.4062/biomolther.2023.072.

Stimulatory Anticancer Effect of Resveratrol Mediated by G Protein-Coupled Estrogen Receptor in Colorectal Cancer

Affiliations
  • 1College of Pharmacy, Duksung Women’s University, Seoul 01369, Republic of Korea
  • 2Duksung Innovative Drug Center, Duksung Women’s University, Seoul 01369, Republic of Korea
  • 3Department of Radiological & Clinical Research, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sci- ences (KIRAMS), Seoul 01812, Republic of Korea
  • 4Department of Surgery, Korea Cancer Center Hospital, KIRAMS, Seoul 01812, Republic of Korea

Abstract

Colorectal cancer (CRC) is one of the most high-risk cancers; however, it has been suggested that estrogen signaling in CRC could have a protective effect. Therefore, we focused on the function of the G protein-coupled estrogen receptor (GPER) among the estrogen receptors in CRC. In this study, we investigated the therapeutic effect of resveratrol via GPER in CRC (RKO and WiDr) cells, CRC cell-derived xenograft models, and organoids (30T and 33T). Resveratrol significantly suppressed cell viability and proliferation in highly GPER-expressing RKO cells compared to that in low GPER-expressing WiDr cells. In xenograft models, resveratrol also delayed tumor growth and exhibited a high survival rate depending on GPER expression in RKO-derived tumors. Furthermore, resveratrol significantly inhibited the viability of organoids with high GPER expression. Additionally, the anticancer effect of resveratrol on CRC showed that resveratrol rapidly responded to GPER, while increasing the expression of p-ERK and Bax and cleaving PARP proteins.

Keyword

Anticancer; Colorectal cancer; Organoid; Xenograft model; Resveratrol; G protein-coupled estrogen receptor
Full Text Links
  • BT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr